Selective uptake of boronophenylalanine by glioma stem/progenitor cells
Document Type
Article
Publication Date
8-1-2012
Abstract
The success of boron neutron capture therapy (BNCT) depends on the amount of boron in cells and the tumor/blood and tumor/(normal tissue) boron concentration ratios. For the first time, measurements of boron uptake in both stem/progenitor and differentiated glioma cells were performed along with measurements of boron biodistribution in suitable animal models. In glioma stem/progenitor cells, the selective accumulation of boronophenylalanine (BPA) was lower, and retention of boron after BPA removal was longer than in differentiated glioma cells in vitro. However, boron biodistribution was not statistically significantly different in mice with xenografts. © 2012 Elsevier Ltd.
Publication Source (Journal or Book title)
Applied Radiation and Isotopes
First Page
1512
Last Page
1518
Recommended Citation
Sun, T., Zhou, Y., Xie, X., Chen, G., Li, B., Wei, Y., Chen, J., Huang, Q., & Du, Z. (2012). Selective uptake of boronophenylalanine by glioma stem/progenitor cells. Applied Radiation and Isotopes, 70 (8), 1512-1518. https://doi.org/10.1016/j.apradiso.2012.04.005